ABPN Addiction Psychiatry Board Certification Practice Test
Build your confidence for ABPN Addiction Psychiatry Board Certification. Practice the concepts, understand the answers, and strengthen your knowledge one question at a time.
Try a sample questionExam overview and details
Addiction psychiatry subspecialty certification covering substance use disorders, opioid use disorder treatment, dual diagnosis, and addiction pharmacotherapy. Administered by American Board of Psychiatry and Neurology. Key domains include Alcohol-related disorders, Caffeine-related disorders, Cannabis-related disorders and Forensic issues pertinent to substance use and addictive disorders. The exam consists of 220 questions over 240 minutes.
Sample Questions
Choose an answer and explore the explanation to see how practice works.
A 24-year-old man intoxicated with PCP has rhabdomyolysis after prolonged physical struggle. He is now calmer after benzodiazepines. Which monitoring is most important over the next several hours?
A 36-year-old man with methamphetamine intoxication is hyperthermic, severely agitated, and restrained by security. Which treatment priority is most important?
A patient uses escalating doses of prescribed diazepam and insists he is not addicted because he takes it for anxiety. He spends large amounts of time obtaining early refills, continues despite falls, and cannot cut down. Which concept best separates physiologic dependence from sedative use disorder?
A 63-year-old man with alcohol use disorder has been abstinent for 3 months on acamprosate. His nephrologist calls because the patient now has chronic kidney disease with estimated creatinine clearance of 24 mL/min. He has no opioid use, normal liver tests, and strong family support. What is the best medication recommendation?
A 62-year-old man in alcohol recovery is prescribed zolpidem nightly after hip surgery. Three months later he takes extra doses, has amnestic nighttime eating, and becomes irritable when he runs out early. Which statement best characterizes the addiction risk?
Exam insights and study advice
Achieving board certification in Addiction Psychiatry has profound real-world impact. It formally designates a psychiatrist as an expert equipped to handle the most challenging cases of substance use disorders, which are often intertwined with other medical and psychiatric conditions. This credential is increasingly required for leadership roles in addiction treatment centers, academic positions, and healthcare system design. It signals to referring physicians, insurers, and patients a deep, verified competency that goes beyond general psychiatry, enabling the certified specialist to implement evidence-based, multidisciplinary treatment plans that can significantly improve patient outcomes and reduce the substantial personal and societal burdens of addiction.
What this exam covers
01Alcohol-related disorders
This specific domain covers alcohol-related disorders, diagnostic criteria, physiological impacts, and important treatment strategies required for clinical practice and professional board evaluation by the certifying medical board.
02Caffeine-related disorders
This section focuses heavily on caffeine-related disorders, acute intoxication characteristics, and recognized withdrawal patterns necessary for accurate clinical identification and proper assessment by qualified medical practitioners during evaluations.
03Cannabis-related disorders
This domain carefully examines cannabis-related disorders, dependency patterns, and the associated clinical manifestations that practitioners encounter during patient evaluations and treatment planning processes within everyday practice environments and clinical care settings.
04Forensic issues pertinent to substance use and addictive disorders
This domain focuses on forensic issues pertinent to substance use and addictive disorders, exploring legal responsibilities, ethical dilemmas, and mandatory reporting guidelines for practitioners navigating complex legal healthcare frameworks.
05Gambling disorder
This specific domain examines gambling disorder, behavioral addiction criteria, and targeted treatment approaches necessary for addressing non-substance-related compulsive behaviors effectively in specialized clinical environments and professional practices today.
06Inhalant-related disorders
This domain focuses on inhalant-related disorders, associated toxicity risks, and behavioral indicators that signify dangerous substance misuse requiring immediate medical intervention and clinical monitoring by trained healthcare professionals.
07Opioid-related disorders
This comprehensive section covers opioid-related disorders, overdose prevention measures, and evidence-based medication-assisted treatments critical for saving lives and maintaining long-term sobriety among affected patients in clinical healthcare settings everywhere.
08Other (or unknown) substance-related disorders
This vital section covers other or unknown substance-related disorders, helping clinicians identify and evaluate emerging psychoactive substances that lack standard classification categories in traditional diagnostic reference manuals used by professionals.
09Other hallucinogen-related disorders
This area addresses other hallucinogen-related disorders, psychological effects, and clinical care standards required for managing acute toxicity and supporting long-term patient recovery processes effectively under standard medical guidelines.
10Other topics related to substance use and addictive disorders
This final domain covers other topics related to substance use and addictive disorders not categorized elsewhere, ensuring a complete evaluation of comprehensive addiction psychiatry competencies tested by the board.
11Phencyclidine-related disorders
This detailed area addresses phencyclidine-related disorders and acute intoxication presentations, focusing on safety protocols and behavioral management techniques required in professional clinical settings and emergency department care environments consistently.
12Sedative-, hypnotic-, or anxiolytic-related disorders
This extensive domain examines sedative-, hypnotic-, or anxiolytic-related disorders alongside potential withdrawal risks that demand careful clinical supervision and monitored detoxification protocols in daily psychiatric and medical practice environments.
13Stimulant-related disorders
This area addresses stimulant-related disorders, physiological consequences, and acute management strategies for patients presenting with severe substance intoxication or dependence during formal medical board examinations and clinical assessments.
14Tobacco-related disorders
This domain focuses on tobacco-related disorders, nicotine dependence mechanisms, and effective cessation strategies designed to improve overall patient health and reduce smoking-related mortality rates across diverse clinical populations.